Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
valuation ratios | |
---|---|
pe ratio | -230.05 |
peg ratio | -5.59 |
price to book ratio | 202.01 |
price to sales ratio | 2.61 |
enterprise value multiple | 94.72 |
price fair value | 202.01 |
profitability ratios | |
---|---|
gross profit margin | 45.41% |
operating profit margin | -0.66% |
pretax profit margin | -1.19% |
net profit margin | -1.12% |
return on assets | -2.37% |
return on equity | 66.22% |
return on capital employed | -5.52% |
liquidity ratio | |
---|---|
current ratio | 0.75 |
quick ratio | 0.75 |
cash ratio | 0.15 |
efficiency ratio | |
---|---|
days of inventory outstanding | 0.00 |
operating cycle | 71.34 |
days of payables outstanding | 60.59 |
cash conversion cycle | 10.75 |
receivables turnover | 5.12 |
payables turnover | 6.02 |
inventory turnover | 0.00 |
debt and solvency ratios | |
---|---|
debt ratio | 0.27 |
debt equity ratio | 9.95 |
long term debt to capitalization | 0.89 |
total debt to capitalization | 0.91 |
interest coverage | 0.00 |
cash flow to debt ratio | -0.40 |
cash flow ratios | |
---|---|
free cash flow per share | -0.21 |
cash per share | 0.20 |
operating cash flow per share | -0.20 |
free cash flow operating cash flow ratio | 1.04 |
cash flow coverage ratios | -0.40 |
short term coverage ratios | 0.00 |
capital expenditure coverage ratio | -24.83 |
Frequently Asked Questions
Champions Oncology, Inc. (CSBR) published its most recent earnings results on 16-12-2024.
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Champions Oncology, Inc. (NASDAQ:CSBR)'s trailing twelve months ROE is 66.22%.
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Champions Oncology, Inc. (CSBR) currently has a ROA of -2.37%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
CSBR reported a profit margin of -1.12% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
Apple's current ratio, which measures its ability to pay short-term obligations, was 0.75 in the most recent quarter. The quick ratio stood at 0.75, with a Debt/Eq ratio of 9.95.